November 06, 2026

News

Weekly Scoop #119

Fertifa acquires menopause specialist Tuune

Fertifa acquires hormonal health specialist Tuune 🤝

‍

Fertifa, the London healthtech run by Eileen Burbidge, has agreed to buy Tuune, whose regulated clinical software helps clinicians deliver personalised hormonal care.Fertifa started in 2019 as a fertility benefits provider and has since expanded into mental health, neurodiversity, weight management and infant care.

‍

"This acquisition takes us another step forward in that mission and at an exciting time, as the Fertifa team continues to expand to cover more underserved healthcare needs for employees."

 

— Eileen Burbidge, Director, Fertifa

‍

‍

‍

‍

‍

Aspen sells European rights to menopause treatment Ovestin for €197M 💊 

South Africa’s Aspen Pharmacare is selling the European commercialisation rights and related IP for Ovestin to Ennogen Healthcare International for €197 million ($220 million). Ovestin contains oestriol, a form of oestrogen, and treats vaginal symptoms associated with menopause. Ennogen will also buy around €4 million of related inventory, and Aspen will keep manufacturing and supplying the active ingredient and cream formulation in Europe for at least 10 years.

‍

‍

‍

‍

‍

Northern Ireland invests £1.95M in endometriosis services 🏥

‍

Health Minister Robbie Butler has announced ÂŁ1.95 million to improve endometriosis care across Northern Ireland. ÂŁ700,000 goes to the two Regional Endometriosis Centres in the Belfast and Western Trusts. A further ÂŁ1.25 million is shared across the five Health and Social Care Trusts to roll out a new Regional Endometriosis Pathway.

‍

‍

‍

‍

‍

Rhode launches $5M women’s health research grant 🎀 

Hailey Bieber’s beauty brand Rhode has launched a $5 million grant programme for women’s health research after Hailey's own postpartum difficulties. It is funded through Rhode’s Future Funds, which commits 2% of net revenue to causes. Over the next three years, the grant will back research, education and care for under-researched conditions, including PMOS, autoimmune diseases and postpartum health. To kick it off, Rhode has donated $1 million to the Foundation for Women’s Health Evergreen Fund.

‍

“As a woman, I feel frustrated by the lack of research, the lack of awareness, the lack of certain conversation around it.”
— Hailey Bieber, Founder, Rhode Beauty

‍

‍

‍

Other news

News
Weekly Scoop #119
Fertifa acquires menopause specialist Tuune
Read now
News
Weekly Scoop #118
Ferring to acquire Gameto for up to $1.38 billion
Read now
News
Weekly Scoop #117
Allara raises $30 million to expand AI-enabled care
Read now
Our first Global Women's Health Investment Report is here — read it now!
Download Report